Npil Research Development

Rediff.com » News » Npil Research Development

News for Npil Research Development

Business

Piramal makes progress on cancer drug research

Piramal Healthcare's drug discovery arm, Piramal Life Sciences Ltd, is planning to move at least three more novel chemical entities under development into the human clinical trial stage within the......

Flu: India safe but ill-equipped on epidemic drugs

Swine flu was first reported in Mexico, SARS and bird flu in China, but India surprisingly escaped being ground zero for any. China: SARS in 2002-2003 and bird flu in 1996, both in the southern......

Piramal Life may develop TB drug

Piramal Life Sciences, the demerged research arm of pharmaceutical major Nicholas Piramal India, may become the first company to successfully develop a tuberculosis drug whose leads are isolated......

Indian pharma cos on R&D drive in 2007

Two years after India entered the product patents regime, the year 2007 saw Indian drug firms striving to shed the copycat image and become innovators with emphasis on research activities even as......

NPIL in cancer drug discovery pact with Merck

Nicholas Piramal India, which on Monday entered into a drug discovery collaboration for two cancer molecules with MSD Pharmaceuticals, the Indian arm of global drug major Merck & Company, is likely......

Rediff News

Npil Research Development

News for Npil Research Development

Piramal makes progress on cancer drug research

Flu: India safe but ill-equipped on epidemic drugs

Piramal Life may develop TB drug

Indian pharma cos on R&D drive in 2007

NPIL in cancer drug discovery pact with Merck

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS